ACADIA Pharmaceuticals: Q1 Earnings Insights

ACADIA Pharmaceuticals ACAD reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

ACADIA Pharmaceuticals missed estimated earnings by 16.67%, reporting an EPS of $-0.7 versus an estimate of $-0.6.

Revenue was up $8.91 million from the same period last year.

Last quarter the company missed on EPS by $0.03 which was followed by a 1.34% drop in the share price the next day.

Here's a look at ACADIA Pharmaceuticals's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.24	-0.26	-0.31	-0.53
EPS Actual	-0.27	-0.09	-0.27	-0.42
Revenue Estimate	135.60M	127.75M	126.15M	111.63M
Revenue Actual	130.76M	131.61M	115.22M	106.55M

To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar